Lipo-γ-AApeptides as a new class of potent and broad-spectrum antimicrobial agents

scientific article published on 17 April 2012

Lipo-γ-AApeptides as a new class of potent and broad-spectrum antimicrobial agents is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1021/JM300274P
P698PubMed publication ID22475244

P50authorHaifan WuQ42182933
Lindsey N ShawQ56191691
P2093author name stringGe Bai
Chuanhai Cao
Jianfeng Cai
Yaogang Hu
Qiao Qiao
Youhong Niu
Lacey Harrington
Whittney N Burda
Shruti Padhee
P433issue8
P304page(s)4003-4009
P577publication date2012-04-17
P1433published inJournal of Medicinal ChemistryQ900316
P1476titleLipo-γ-AApeptides as a new class of potent and broad-spectrum antimicrobial agents
P478volume55

Reverse relations

cites work (P2860)
Q40076286Advances in Development of Antimicrobial Peptidomimetics as Potential Drugs
Q38809110Antimicrobial AApeptides.
Q42232901Antimicrobial peptidomimetics: reinterpreting nature to deliver innovative therapeutics.
Q38956247Design, synthesis and characterization of fMLF-mimicking AApeptides.
Q36899892Designed supramolecular filamentous peptides: balance of nanostructure, cytotoxicity and antimicrobial activity.
Q89201772Developments with investigating descriptors for antimicrobial AApeptides and their derivatives
Q37684752Helical 1:1 α/Sulfono-γ-AA Heterogeneous Peptides with Antibacterial Activity
Q64927595Isosteric substitution in cationic-amphiphilic polymers reveals an important role for hydrogen bonding in bacterial membrane interactions.
Q39076004Lipidated cyclic γ-AApeptides display both antimicrobial and anti-inflammatory activity.
Q39733235Lipidated peptidomimetics with improved antimicrobial activity.
Q89116193Lipidated α/α-AA heterogeneous peptides as antimicrobial agents
Q47595624Membrane-Active Hydantoin Derivatives as Antibiotic Agents.
Q40072170Membrane-active macromolecules kill antibiotic-tolerant bacteria and potentiate antibiotics towards Gram-negative bacteria.
Q27312185Membrane-active macromolecules resensitize NDM-1 gram-negative clinical isolates to tetracycline antibiotics
Q50100988Novel bis-cyclic guanidines as potent membrane-active antibacterial agents with therapeutic potential.
Q27026959Peptidomimetics as a new generation of antimicrobial agents: current progress
Q37608063Polycarbonates with Potent and Selective Antimicrobial Activity toward Gram-Positive Bacteria.
Q36850129Selective Membrane Disruption Mechanism of an Antibacterial γ-AApeptide Defined by EPR Spectroscopy
Q42182872Short antimicrobial lipo-α/γ-AA hybrid peptides
Q37692425Small Antimicrobial Agents Based on Acylated Reduced Amide Scaffold
Q90609481Small antibacterial molecules highly active against drug-resistant Staphylococcus aureus
Q37713223Structure and Function of AApeptides.
Q40251304The development of antimicrobial a-AApeptides that suppress proinflammatory immune responses.
Q38855323The development of antimicrobial γ-AApeptides
Q34854161The synthetic amphipathic peptidomimetic LTX109 is a potent fungicide that disturbs plasma membrane integrity in a sphingolipid dependent manner
Q28546904Virtual Screening of Peptide and Peptidomimetic Fragments Targeted to Inhibit Bacterial Dithiol Oxidase DsbA
Q38899476γ-AApeptides as a New Class of Peptidomimetics.
Q48609225γ-AApeptides as a new strategy for therapeutic development
Q92527921γ-AApeptides-based Small Molecule Ligands That Disaggregate Human Islet Amyloid Polypeptide
Q35930663γ-AApeptides: Design, Structure, and Applications

Search more.